Alcoholic liver damage–toxicity, autoimmunity and allergy

Abstract

Clinical & Experimental AllergyVolume 24, Issue 6 p. 503-507 Free Access Alcoholic liver damage–toxicity, autoimmunity and allergy N. SHERON, N. SHERON University Medicine (South Block), Room LD68, Level D, South Laboratory & Pathology Block, Southampton General Hospital, Tremona Road, Southampton SO9 4XY UKSearch for more papers by this author N. SHERON, N. SHERON University Medicine (South Block), Room LD68, Level D, South Laboratory & Pathology Block, Southampton General Hospital, Tremona Road, Southampton SO9 4XY UKSearch for more papers by this author First published: June 1994 https://doi.org/10.1111/j.1365-2222.1994.tb00945.xCitations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Triger DR, Wright R. Hyperglobulinaemia in liver disease. Lancet 1973; 1494– 6. 2 van Epps E, Husby G, Williams Jr RC, Strickland RG. Liver disease–a prominent cause of serum IgE elevation. Clin Exp Immunol 1976; 23: 444– 50. 3 Levo Y, Shalit M. Serum IgE levels in patients with liver disease. Ann Allergy 1981; 47: 456– 9. 4 Minuk GY, Boyd ND, Matheson DS, Fritzler MJ, Green BJ. Serum immunoglobulin E levels in patients with primary biliary cirrhosis. J Allergy Clin Immunol 1989; 83: 462– 6. 5 Vidal C, Gonzalez Quintela AG, Millán I, Gude F, Cuervas-Mons V. Serum IgE levels in liver cirrhosis. Contrasting results in alcoholic and non-alcoholic patients. Clin Exp Allergy 1994; 24: 540– 8. 6 Paronetto F. Immunologic reactions in alcoholic liver disease. Semin Liver Dis 1993; 13: 183– 95. 7 Rolando N, Harvey F, Brahm J, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990; 11: 49– 53. 8 Rolando N, Harvey F, Brahm J, et al. Fungal infection: a common, unrecognized complication of acute liver failure. J Hepatol 1991; 12: 1– 9. 9 Todo S, Tzakis A, Abu Elmagd K, et al. Clinical intestinal transplantation. Transplant Proc 1993; 25: 2195– 7. 10 Sarnacki S, Calise D, Brousse N, Cerf Bensussan N, Revillon Y. [A study of tolerance induced by liver transplantation on intestinal graft in the rat]. Chirurgie 1991; 117: 710– 6. 11 Leevy CM. Cirrhosis in alcoholics. Med Clin N Am 1968; 52: 1445– 51. 12 Lieber CS. Metabolic effects of ethanol and its interaction with other drugs, hepatotoxic agents, vitamins, and carcinogens. A 1988 update. Semin Liver Dis 1988; 8: 47– 68. 13 Orrego H, Blake JE, Blendis LM, Medline A. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 1987; 92: 208– 14. 14 Sorensen TI, Orholm M, Bentsen KD, Hoybye G, Eghoje K, Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984; 2: 241– 4. 15 Hardison WG, Lee FI. Progosis in the acute liver disease of the alcoholic patient. N Engl J Med 1966; 275: 61– 6. 16 Carithers RLJ, Herlong HF, Diehl AM, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 1989; 110: 685– 90. 17 Theodossi A, Eddleston AL, Williams R. Controlled trial of methylprednisolone therapy in severe alcoholic hepatitis. Gut 1982; 32: 75– 9. 18 Carithers RLJ, Herlong HF, Diehl AM, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 1989; 110: 685– 90. 19 Bedossa P, Degott C, Duchatelle V, et al. A polymorphonuclear cell infiltrate in liver biopsy of patients treated with prednisolone for severe alcoholic hepatitis is associated with a favourable outcome. Gastro 1992; 102(abstr): A780. 20 McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989; 9: 349– 51. 21 Bird GLA, Sheron N, Goka AKJ, et al. Increased plasma tumour necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990; 112: 917– 20. 22 Sheron N, Bird G, Koskinas J, et al. Circulating and Tissue Levels of the Neutrophil Chemotaxin Interleukin-8 Are Elevated in Severe Acute Alcoholic Hepatitis, and Tissue Levels Correlate with Neutrophil Infiltration. Hepatology 1993; 18: 41– 6. 23 Lieber CS. Biochemical factors in alcoholic liver disease. Semin Liver Dis 1993; 13: 136– 53. 24 Devor EJ, Reich T, Cloninger CR. Genetics of alcoholism and related end-organ damage. Semin Liver Dis 1988; 1– 11. 25 Niemela O, Juvonen T, Parkkila S. Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption. J Clin Invest 1991; 87: 1367– 74. 26 Sillanaukee P, Seppa K, Koivula T, et al. Acetaldehyde-modified hemoglobin as a marker of alcohol consumption: Comparison of two new methods. J Lab Clin Med 1992; 120: 42– 7. 27 Hoerner M, Behrens UJ, Worner TM, et al. The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts. Hepatology 1988; 8: 569– 74. 28 Hoerner M, Behrens UJ, Worner TM, et al. The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts. Hepatology 1988; 8: 569– 74. 29 Terabayashi H, Kolber MA. The generation of cytotoxic lymphocytes-T against acetaldehyde-modified syngeneic cells. Alcohol Clin Res 1990; 14: 893– 9. 30 Omar R, Pappolla M, Saran B. Immunocytochemical detection of the 70-kd heat shock protein in alcoholic liver disease. Arch Pathol Lab Med 1990; 114: 589– 92. 31 Li GC. Induction of thermotolerance and enhanced heat shock protein synthesis in Chinese hamster fibroblasts by sodium arsenite and by ethanol. J Cell Physiol 1983; 115: 116– 22. 32 Zatloukal K, Sohar R, Lackinger E, Denk H. Induction of heat shock proteins in short-term cultured hepatocytes derived from normal and chronically griseofulvin-treated mice. Hepatology 1988; 8: 607– 12. 33 Koskinas J, Winrow V, Bird GL, et al. IgE antibody to the 65kD heat shock protein (HSP) is characteristic of alcoholic hepatitis. J Hepatol 1991; 13(suppl. 2): S39. 34 French SW, Burbige EJ, Tarder G, et al. Lymphocyte sequestration by the liver in alcoholic hepatitis. Arch Pathol Lab Med 1979; 103: 146– 52. 35 Peters M, Liebman HA, Tong MY, Tinberg HM. Alcoholic hepatitis: Granulocyte chemotactic factor from Mallory body-stimulated human peripheral blood mononuclear cells. Clin Immunol Immunopathol 1983; 28: 418– 30. 36 Kanagasundaram N, Nakumu S, Chen T, Leevy CM. Alcoholic hyaline antigen (AHAg) and antibody (AHAb) in alcoholic hepatitis. Gastroenterology 1977; 73: 1368– 73. 37 Kehl A, Schober A, Junge U, Winckler K. Solid-phase radioimmunoassay for detection of alcoholic hyalin antigen (AHAg) and antibody (anti-AH). Clin Exp Immunol 1981; 43: 215– 21. 38 Zetterman RK, Luisada-Opper A, Leevy CM. Alcoholic hepatitis: Cell mediated immunological response to alcholic hyalin. Gastroenterology 1976; 70: 382– 84. 39 Gluud C, Hardt F, Aldershvile J, et al. Isolation of Mallory bodies and an attempt to demonstrate cell mediated immunity to Mallory body isolate in patients with alcoholic liver disease. J Clin Pathol 1981; 34: 1010– 16. 40 Govindarajan S, Tinberg H, Radvan G. Circulating immune complexes in alcoholic hepatitis. Clin Res 1982; 30: 995–Abstract. 41 Burns J, D'Ardenne AJ, Morton JA, McGee JO'D. Immune complex nephritis in alcoholic cirrhosis. Detection of Mallory body antigen in complexes by means of monoclonal antibodies to Mallory bodies. J Clin Pathol 1983; 36: 751– 5. 42 Barbatis, C Woods J, Morton JA, et al. Immunohistochemical analysis of HLA (A,B,C) antigens in liver disease using a monoclonal antibody. Gut 1981; 22: 985– 91. 43 De Vos R, De Wolf-Peeters C, van den Oord JJ, Desmet V: Ultrastructural immunocytochemical demonstration of HLA class I antigens in human pathological liver tissue. Hepatology 1985; 5: 1071– 5. 44 Bergroth V, Konttinen YT, Segerberg-Konttinen M, et al. Phenotypic in situ characterization of lymphocytes in mild alcoholic liver disease. Acta Pathol Microbiol Immunol Scand 1986; 94: 337– 41. 45 van de Wiel A, Schuurman HJ, Kater L. Alcoholic liver disease: an IgA-associated disorder. Scand J Gastroenterol 1987; 22: 1025– 30. 46 van de Wiel A, Delacroix DL, van Hattum J, Schuurman HJ, Kater L. Characteristics of serum IgA and liver IgA deposits in alcoholic liver disease. Hepatology 1987; 7: 95– 9. 47 van de Wiel A, van Hattum J, Schuurman HJ, Kater L. Immunoglobulin A in the diagnosis of alcoholic liver disease. Gastroenterology 1988; 94: 457– 62. 48 Nagore N, Scheuer PJ. Does a linear pattern of sinusoidal IgA deposition distinguish between alcoholic and diabetic liver disease Liver 1988; 8: 281– 6. 49 van de Wiel A, Schuurman HJ, van Riessen D, et al. Characteristics of IgA deposition in liver and skin of patients with liver disease. Am J Clin Pathol 1986; 86: 724– 30. 50 Si L, Whiteside TL, Schade RR, van Thiel DH. Lymphocyte subsets studied with monoclonal antibodies in liver tissues of patients with alcoholic liver disease. Alcohol Clin Exp Res 1983; 7: 431– 5. 51 Chedid A, Mendenhall CL, and the Veterans Administration Cooperative Study #275. Cell-mediated immunity in alcoholic liver disease. Alcohol, Immunomodulation, and AIDS. New York , Alan R. Liss, 1990; 321. 52 Takahashi T, Kamimura T, Ichida F. Ultrastructural findings on polymorphonuclear leucocyte infiltration and acute hepatocellular damage in alcoholic hepatitis. Liver 1987; 7: 347– 58. 53 Nagore N, Scheuer PJ. The pathology of diabetic hepatitis. J Pathol 1988; 156: 155– 60. 54 Burra P, Hubscher SG, Shaw J, Elias E, Adams DH. Is the intercellular adhesion molecule-1/leukocyte function associated antigen 1 pathway of leukocyte adhesion involved in the tissue damage of alcoholic hepatitis Gut 1992; 33: 268– 71. 55 Spinozzi F, Guerciolini R, Gerli R, et al. Evidence for the in vivo activation of helper T cells and of the monocyte macrophage system. Int Arch Allergy Appl Immunol 1986; 80: 361– 8. 56 Deviere J, Denys C, Schandene L, et al. Decreased proliferative activity associated with activation markers in patients with alcoholic liver cirrhosis. Clin Exp Immunol 1988; 72: 377– 82. 57 Conroy C, Allen JI. Ethanol induces expression of class in major histocompatibility antigens on human periphes: blood monocytes. (Abstract). Hepatology 1988; 8: 1235. 58 Cook RT, Gravey MJ, Booth BM, et al. Activated C cells and HLA DR expression in alcoholics without over liver disease. J Clin Immunol 1991; 11: 246– 53. 59 Milli F, Flanders WD, Boring Jr, et al. The associations of alcohol drinking and drinking cessation to measures of the immune system in middle-aged men. Alcohol Clin Exp Res 1992; 16: 688– 94. 60 Ishimaru H, Matsuda T. T cell subsets (Tc, Th, Ts, Tsi) and IL2 receptor-bearing cells in peripheral blood of patients in the acute phase of alcoholic hepatitis. Alcohol Alcohol 1990; 25: 353– 8. 61 Roselle GA, Mendenhall CL, Grossman CJ, Weesner RE. Lymphocyte subset alterations in patients with alcoholic hepatitis. J Clin Lab Immunol 1988; 26: 169– 73. 62 Ruibal-Ares B, de la Barrera S, Sasiain MC, Colombato LA. Cell-mediated immunity in alcoholic liver cirrhosis. Medicina (B Aires) 1987; 47: 27– 32. 63 Mutchnick MG, Lee HH. Impaired lymphocyte proliferative response to mitogen in alcoholic patients. Absence of a relation to liver disease activity. Alcohol Clin Exp Res 1988; 12: 155– 8. 64 Drew PA, Clifton PM, LaBrooy JT, Shearman DJC. Polyclonal B cell activation in alcoholic patients with no evidence of liver dysfunction. Clin Exp Immunol 1984; 57: 479– 86. 65 Giron JA, Alvarez-Mon M, Menendez-Caro JL, et al. Increased spontaneous and lymphokine-conditioned IgA and IgG synthesis by B cells from alcoholic cirrhotic patients. Hepatology 1992; 16: 664– 70. 66 Rodriguez MA, Montano JD, Willims RC. Immunoglobulin production by peripheral blood mononuclear cells in patients with alcoholic liver disease. Clin Exp Immunol 1984; 55: 369– 76. 67 Nouri-Aria KT, Alexander CJM, Portmann BC, et al. T and B cell function in alcoholic liver disease. J Hepatol 1986; 2: 195– 207. 68 Prieto JA, Mutchnick MG. Suppressor T-cell activity (SCA) in acute and chronic alcoholic liver disease. (Abstract). Gastroenterology 1980; 79: 1046. 69 Lue SL, Paronetto F, Lieber CS. Cytotoxicity of mono-nuclear cells and vulnerability of hepatocytes in alcoholic fatty liver of baboons. Liver 1981; 1: 264– 7. 70 Erenoglu E, Edreira JG, Patek AJ Jr. Observations on patients with Laennec's cirrhosis receiving alcohol while on controlled diets. Ann Intern Med 1964; 60: 814– 22. 71 Actis GC, Ponzetto A, Rizzetto M, Verme G. Cell-mediated immunity to acetaldehyde in alcoholic liver disease demonstrated by leukocyte migration test. Dig Dis 1978; 23: 883– 6. 72 Cochrane AMG, Moussouros A, Portmann B, et al. Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease. Gastroenterology 1977; 72: 918– 23. 73 Poralla T, Hutteroth TH, Meyer zum Buschenfelde KH. Cellular cytotoxicity against autologous hepatocytes in alcoholic liver disease. Liver 1984; 4: 117– 21. 74 Takase S, Tsutsumi M, Kawahara H, et al. Factors relating to the progression of alcoholic liver injury. Abstract. Hepatology 1992; 16: 598. 75 Crossley IR, Neuberger J, Davis M, et al. Ethanol metabolism in the generation of new antigenic determinants on liver cells. Gut 1986; 27: 186– 9. 76 Anthony R, Farquharson M, MacSween RNM. Liver membrane antibodies in alcoholic liver disease. II. Antibodies to ethanol-altered hepatocytes. J Clin Pathol 1983; 36: 1302– 8. 77 Burt AD, Anthony RS, Hislop WS, et al. Liver membrane antibodies in alcoholic liver diseases. I. Prevalence and immunoglobulin class. Gut 1982; 23: 221– 5. 78 Frazer IH, Kronborg IJ, Mackay IR; Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH. Clin Exp Immunol 1983; 54: 213– 8. 79 Israel Y, Hurwitz E, Niemela O, Arnon R. Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts. Proc Natl Acad Sci USA 1986; 83: 7923– 7. 80 Meliconi R, Miglio F, Stancari MV, et al. Hepatocyte membrane-bound IgG and circulating liver-specific auto-antibodies in chronic liver disease: Release to hepatitis B virus serum markers and liver histology. Hepatology 1983; 3: 155– 61. 81 Perperas A, Santoulas T, Portmann B, et al. Autoimmunity to a liver membrane lipoprotein and liver damage in alcoholic liver disease. Gut 1981; 22: 149– 52. 82 Treichel U, Poralla T, Hess G, et al. Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology 1990; 11: 606– 12. 83 Sheron N, Bird G, Goka J, Alexander G, Williams R. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin Exp Immunol 1991; 84: 449– 53. 84 Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991; 13: 267– 76. 85 Sheron N, Ceska M, Lindley I, Williams R. Ethanol suppresses in vitro interleukin 8 synthesis production in Hep-G2 cells. J Hepatol 1992; 16(suppl 1): S61. 86 Bird GLA, Aria KN, Daniels H, Alexander GJ, Williams R. Contrasts in interleukin-1 and interleukin-2 activity in alcoholic hepatitis and cirrhosis. Alcohol Alcohol 1989; 24: 541– 6. Citing Literature Volume24, Issue6June 1994Pages 503-507 ReferencesRelatedInformation